European Commission Approves Eliquis for Deep Vein Thrombosis, Pulmonary Embolism

Drug Industry Daily
The European Commission has approved an expanded indication for the blood thinner Eliquis to treat deep vein thrombosis and pulmonary embolism and to prevent recurrent DVT and PE in adults, Bristol-Myers Squibb and Pfizer said Tuesday.

To View This Article:


Subscribe To Drug Industry Daily